Title: |
Chinese Guidelines for the Diagnosis and Treatment of Vascular Cognitive Impairment (2024 Edition) |
Edition: |
Original |
Classification: |
Standard guideline |
Field: |
Comprehensive guideline |
Countries and regions: |
China |
Guidelines users: |
This guideline is applicable to medical institutions and management organizations at all levels for organizing and carrying out the diagnosis and treatment of patients with VCI. The users of this guideline include, but are not limited to, healthcare professionals involved in the prevention, diagnosis, treatment, and management of VCI in medical institutions at various levels. |
Evidence classification method: |
The grade/quality evaluation of evidences adopts the AHA/ASA Guidelines Standardized Rating System |
Development unit: |
Chinese Stroke Association Vascular Cognitive Impairment Subcommittee |
Registration time: |
2024-05-03 |
Registration number: |
PREPARE-2024CN611 |
Purpose of the guideline: |
This guideline aims to promote clinical physicians from related departments such as neurology, geriatrics, general medicine, psychiatry, rehabilitation, cardiology, etc., to standardize the clinical classification, diagnostic criteria and prevention strategies of VCI, and effectively improve the prognosis of patients and reduce the social burden. |